3Leuschner M,Dietrich C F, You T,et al. Characterisation of patients with primary biliary cirrhosis responding to long term ursodeoxycholic acid treatment[J]. Gut, 2000,46:121-126.
4Dickson ER,Grambsch PM, Fleming TR, et al. Prognosis in primary biliary cirrhosis: model for decision making[J].Hepatology, 1989,10:1-7.
5Poupon RE, Ouguerram K, Chretien Y, et al. Cholesterollowing effect of ursodeoxycholic acid in patients with primary biliary cirrhosis[J]. Hepatology, 1993,17:577-582.
6Klein R, Huizenga SR, Gips CH, et al. Antimitochondrial antibody profiles in patients with primary biliary cirrhosis before orthotopic liver transplantation and titers of antimitochondrial antibody-subtypes after transplantation[J]. J Hepatol, 1994,20:181-189.
7Metcalf JV, Mitchison HC, Parmer JM, et al. Natural history of early primary biliary cirrhosis[J]. Lancet, 1996,348:1399-1402.
8Heathcote EJ. Management of primary biliary cirrhosis[J].Hepatology, 2000,31:1005-1013.
9Lacerda MA, Ludwig J, Dickson ER, et al. Antimitochondrial antibody-negative primary biliary cirrhosis[J]. Am J Gastroenterol, 1995,90: 247-249.
10Bandin O, Courvalin J, Poupon R, et al. Specificity and sensitivity of gp210 autoantibodies detected using an enzyme-linked immunosorbent assay and a synthetic polypeptide in the diagnosis of primary biliary cirrhosis[J]. Hepatology, 1996,23:1020-1024.
